Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-10 of 15 (Search time: 0.001 seconds).
previous
1
2
next
Item hits:
Preview
Issue Date
Title
Author(s)
2006
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
Druker, B.
;
Guilhot, F.
;
O'Brien, S.
;
Gathmann, I.
;
Kantarjian, H.
;
Gattermann, N.
;
Deininger, M.
;
Silver, R.
;
Goldman, J.
;
Stone, R.
;
Cervantes, F.
;
Hochhaus, A.
;
Powell, B.
;
Gabrilove, J.
;
Rousselot, P.
;
Reiffers, J.
;
Cornelissen, J.
;
Hughes, T.
;
Agis, H.
;
Fischer, T.
;
et al.
2008
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia
le Coutre, P.
;
Ottmann, O.
;
Giles, F.
;
Kim, D.
;
Cortes, J.
;
Gattermann, N.
;
Apperley, J.
;
Larson, R.
;
Abruzzese, E.
;
O'Brien, S.
;
Kuliczkowski, K.
;
Hochhaus, A.
;
Mahon, F.
;
Saglio, G.
;
Gobbi, M.
;
Kwong, Y.
;
Baccarani, M.
;
Hughes, T.
;
Martinelli, G.
;
Radich, J.
;
et al.
2009
Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia
Hochhaus, A.
;
O'Brien, S.
;
Guilhot, F.
;
Druker, B.
;
Branford, S.
;
Foroni, L.
;
Goldman, J.
;
Muller, M.
;
Radich, J.
;
Rudoltz, M.
;
Mone, M.
;
Gathmann, I.
;
Hughes, T.
;
Larson, R.
2009
Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive value
Hochhaus, A.
;
Muller, M.
;
Radich, J.
;
Branford, S.
;
Kantarjian, H.
;
Hanfstein, B.
;
Rousselot, P.
;
Kim, D.
;
Lipton, J.
;
Bleickhardt, E.
;
Lambert, A.
;
Hughes, T.
2006
Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia
Branford, S.
;
Cross, N.
;
Hochhaus, A.
;
Radich, J.
;
Saglio, G.
;
Kaeda, J.
;
Goldman, J.
;
Hughes, T.
2004
Monitoring of minimal residual disease in chronic myeloid leukemia
Faderl, S.
;
Hochhaus, A.
;
Hughes, T.
2008
International standardisation of quantitative real-time RT-PCR for BCR-ABL
Cross, N.
;
Hughes, T.
;
Hochhaus, A.
;
Goldman, J.
2003
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia
O'Brien, S.
;
Guilhot, F.
;
Larson, R.
;
Gathmann, I.
;
Baccarani, M.
;
Cervantes, F.
;
Cornelissen, J.
;
Fischer, T.
;
Hochhaus, A.
;
Hughes, T.
;
Lechner, K.
;
Nielsen, J.
;
Rousselot, P.
;
Reiffers, J.
;
Saglio, G.
;
Shepherd, J.
;
Simonsson, B.
;
Gratwohl, A.
;
Goldman, J.
;
Kantarjian, H.
;
et al.
2003
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
Hughes, T.
;
Kaeda, J.
;
Branford, S.
;
Rudzki, Z.
;
Hochhaus, A.
;
Hensley, M.
;
Gathmann, I.
;
Bolton, A.
;
van Hoomissen, I.
;
Goldman, J.
;
Radich, J.
2009
Clinical strategies to achieve an early and successful response to tyrosine kinase inhibitor therapy
Hughes, T.
;
Hochhaus, A.
Discover
Author
8
Radich, J.
7
Goldman, J.
6
Branford, S.
5
Cortes, J.
5
Larson, R.
5
Saglio, G.
4
Gathmann, I.
4
Guilhot, F.
4
Kantarjian, H.
4
Kim, D.
.
next >
Subject
12
Humans
10
Pyrimidines
9
Benzamides
9
Imatinib Mesylate
9
Leukemia, Myelogenous, Chronic, B...
9
Piperazines
7
Antineoplastic Agents
7
Fusion Proteins, bcr-abl
6
Female
6
Male
.
next >
Date issued
7
2009
2
2008
2
2006
2
2004
2
2003